Axcella Therapeutics Misses Q4 EPS by 2c

  • Investing.com
Axcella Therapeutics Misses Q4 EPS by 2c

Axcella Therapeutics (NASDAQ: AXLA ) reported Q4 EPS of ($0.46), $0.02 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Axcella Therapeutics click here .

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles